Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM7VG8L)

Drug Name

MTC-896 Drug Info

Synonyms

MC-5 antagonists (dermatological disease), Mimetica

Indication

Disease Entry	ICD 11	Status	REF
Seborrhea	ED91.2	Phase 2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Melanocortin receptor 5 (MC5R)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
JNJ-10229570	DMY7Q3I	Acne vulgaris	ED80	Phase 2	[3]
MT-II	DMKT1DA	Female sexual arousal dysfunction	HA01.1	Investigative	[4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	ClinicalTrials.gov (NCT02395549) A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Avarx.
3	A melanocortin receptor 1 and 5 antagonist inhibits sebaceous gland differentiation and the production of sebum-specific lipids. J Dermatol Sci. 2011 Jul;63(1):23-32.
4	The role of melanocortins in body weight regulation: opportunities for the treatment of obesity. Eur J Pharmacol. 2002 Apr 12;440(2-3):141-57.